Abac Nest Ventures’ Post

So many great news hit Skåne and the life science community last week! Ebba Fåhraeus and her team at SmiLe, a Swedish life science venture hub, was awarded as one of the 125 hubs (out of 2000 organizations!) with the highest score on the ”Europe’s Leading Start-up Hubs 2024” awards list by Financial Times and Statista. The awards list is an initiative aimed at highlighting incubation and acceleration programs that contribute to the success of startups across Europe. The assessment criteria included alumni feedback (#cantargia #acrivontherpaeutics #RedGleadDiscovery #cellevate #redoxis #SARomicsBiostructures #SAGADiagnostics #neoalamedical #Gedeabiotech #Speximo #immunovia and many other companies!) and also on expert recommendations. The future looks bright for SmiLe companies!      Another great news was that the one-and-only 😊 Ebba Fåhraeus was appointed as a member of the Swedish Government Office’s advisory group for life science by Ebba Busch (Minister for the Ministry of Climate and Enterprise), which consists of experts and representatives from, among others, healthcare, academic institutions, industry, and patients. Great initiative of Jeanette Edblad, who’s leading the Life science office at the dept, to increase coordination within the life science sector in Sweden. The purpose of the reference group is to exchange knowledge, provide insights into sector developments, and support the implementation of the national life science strategy. Last, but not least, is the news that Asgard Therapeutics, a privately held preclinical stage biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, raised 30 M€, lead by RV Invest, and co-funded by Johnson & Johnson Innovation – JJDC, Inc., Novo Holdings, Boehringer Ingelheim Venture Fund, and Industrifonden. Congratulations to Asgard team for pulling this through in such fund-raising challenging times and also looking forward following your further accomplishments! There are several other good examples of how life sciences companies in the Region Skåne has reached one milestone after another, and therefore also been able to raise funds for future achievements #xinnate #gedeabiotech #acucort #aptahem #CLS To me, these news are acknowledgements for the devotion, engagement, hard work and stubbornness from various parts (researchers, business coaches, investors, consultants, entrepreneurs, managements, boards, industry, healthcare, partners, infrastructure, media communication and other stakeholders) has put into the life science community. 

Last week's digital health news 🚀👇 💰 From the funds 🇱🇺 David Buller and Laurent van Lerberghe unveiled KELES, a €250 million fund to invest in digital health. 🇨🇿 Tensor Ventures launched a €50 million fund to invest in quantum, biotech, and climate technologies. 💸 From the startups 🇬🇧 Basecamp Research raised $60 million to build a "GPT for biology." (Singular, Broad Institute of MIT and Harvard) 🇺🇸 VieCure secured $45 million to accelerate the adoption of the first AI-based community oncology care platform. (Northpond Ventures) 🇫🇷 Qantev raised €30 million for its AI-powered platform assisting health insurers in decision-making. (Blossom Capital, Elaia, Omnes Capital, RAISE) 🇺🇸 MiLaboratories raised $10 million for its platform aimed at accelerating genomic research (Kfund, Acrobator Ventures, EGB Capital, Courtyard Ventures, Somersault Ventures, Speedinvest, Ten13) 🇺🇸 Rezilient Health announced a $10 million funding round to provide hybrid primary care. (Govo Venture Partners) 🇫🇷 Generare raised €5 million to discover new drugs using microbial DNA. (Teampact.ventures, Galion.exe, VIVES Partners) 🇺🇸 LEVY Health secured $4.5 million to help women identify fertility issues earlier. (XYZ Venture Capital, Atlantic Labs, Possible Ventures) 🧐 The Curious Mind 🎖️ Demis Hassabis and John Jumper, CEO and director of Google DeepMind, were awarded the Nobel Prize in Chemistry for developing AlphaFold, an AI system that predicts the 3D structure of proteins. 🇨🇦 Alan became the first new health insurance company in Canada in nearly 70 years. 🤖 Vivid Mind enables doctors to detect dementia by analyzing patients' voice patterns. Find all the details here (in French 🇫🇷): https://lnkd.in/etHCDBnA

🌟 Exciting advancements in longevity and rejuvenation were discussed at the Rejuvenation Startup Summit Berlin 2024! Cutting-edge research, innovative startups, and visionary scientists are redefining what’s possible in extending our healthspan and improving quality of life. As someone deeply invested in health and wellness, I’m inspired by the potential these developments hold for human well-being. 🌿✨ For more insights, check out the full article on Medium here: #Longevity #HealthTech #ExpandHealthspan #Rejuvenation #ReverseAging #StopAging #InnovativeHealthcare

Full body scans: new emerging HealthTech sub sector will be 'one to watch in 2024' There is a growing interest in full body scans among healthtech startups and investors. These scans can be used to detect a variety of health conditions, including cancer, heart disease, and diabetes. They can also be used to track changes in health over time. > One of the most notable investments in a full body scan healthtech startup is the $65 million Series A funding round that Neko Health raised in July 2023. Neko Health is a Swedish startup that has developed a proprietary full body scanning system that uses AI to detect a variety of health conditions. The company plans to use the funding to expand its operations and bring its scanning system to more people. > Another notable full body scan healthtech company Butterfly Network, has raised a total of $530M in funding over 5rounds and listed on the NYSE on Feb 16, 2021 valued at $1.5 Billion. > The investment in full body scan healthtech startups is a sign of the growing potential of this technology. As the technology continues to develop, it is likely that we will see even more investment in this area. Here are some of the factors that are driving investment in full body scan healthtech startups: > The increasing prevalence of chronic diseases. Chronic diseases are a major burden on the healthcare system. Full body scans can be used to detect chronic diseases early, which can help to improve outcomes and reduce costs. > The aging population. The global population is aging, and this is leading to an increase in the demand for preventive healthcare services. Full body scans can be used to assess the overall health of older adults and identify potential health problems. Overall, the investment in full body scan healthtech startups is a positive development. This technology has the potential to improve the health of millions of people and reduce the cost of healthcare. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies > HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i https://lnkd.in/eSgEy5M7

🌟 Investment Opportunity in IBIONS 🌟 We are excited to announce the current round of #funding we are in at IBIONS. For those who are not familiar with us yet, at IBIONS, we are revolutionizing #oncological treatment through a nutritional approach backed by the latest scientific evidence. 🧬📑 Our method amplifies therapeutic benefits and improves the quality of life for #cancer patients, and thanks to our telemedicine platform IBIONS360 (soon with #ArtificialIntelligence 🤖), we will be able to offer this service on a large scale. 📈🩺📱 So far, we have achieved significant milestones: 🎯 We have impacted the lives of hundreds of people through our service, seminars, conferences, and talks. 🚀 We have participated in accelerators like Lanzadera and AgrotecUV, and programs like Llamp 3i 2023 (Llamp Tech Transfer) and Emprende in-Health (UnLimited Spain / Lilly España) which guide projects with high impact potential. Currently, we are part of the Fundación Ship2B and Impact Hub Madrid impact acceleration program, aimed at projects with impact in health, wellness, and environmental areas. 🏆 We have won the E-Dea Salud award promoted by the #PfizerFoundation and have been selected among the top 100 companies in Scientific Parks in the country by the Spanish Association of Science and Technology Parks (Asociación de Parques Científicos y Tecnológicos de España (APTE)). 🏦 We have been granted various public aids, including an Activa Startup and a participative loan from ENISA (LEAN FINANCE | Finanzas para startups y pymes) in the Digital Innovators line. 🚀 Funding Round: We are excited to invite you to be part of this project! We have opened a funding round with the aim of raising 250,000€ in private capital, and so far, we have 77,000€ already committed. In broad strokes, this will allow us to implement artificial intelligence in our IBIONS360 platform, hire specialized professionals in programming, research, nutrition, and medicine, and launch marketing campaigns. 💪 How can you join? Starting from a minimum ticket of 5,000€, #investors who align with our values and want to invest smart money, and who, in addition to seeking returns on their investments, are also committed to contributing to positive societal change. If you are interested in learning more about the project, do not hesitate to contact us. Together, we can make a real change in oncological treatment possible! 📥 Download the Deck Here → https://lnkd.in/gjKxe4rA

Childhood Friends Launch Legacy Venture Capital to Disrupt Healthcare Two childhood friends, Tiffany Pham and Diane Shao, MD, PhD, have launched Legacy Venture Capital, a firm poised to disrupt healthcare by investing in early-stage life science companies. Combining Pham's business acumen and Shao's scientific expertise, they aim to bridge the gap between groundbreaking research and commercial success. Legacy VC focuses on supporting innovators in building inclusive, world-changing companies that address widespread human health needs. The fund targets the intersection of rigorous science and compelling business opportunities, focusing on immunologic, metabolic, mental, genetic, and reproductive health. The duo's unique blend of skills and experience positions them to make a significant impact on the life sciences landscape. Their journey is a testament to the power of collaboration and the importance of leveraging diverse perspectives to drive innovation. https://lnkd.in/em2mYxjM William Hahn, Dana-Farber Cancer Institute, Harvard Medical School, James Benedict, BeDoWin360 Capital Left Tackle Capital #healthcare #venturecapital #lifesciences #innovation #collaboration

Adopter categories When innovation is introduced into any social system, there are very few people to immediately accept and put them into use and some farmers take very long time to accept and use it. All farmers do no adopt at the same time and differ in their approaches. Apart from other factors, one of the concepts that brings variation among farmers is innovativeness. Some innovations are readily accepted by farmers, while some others are not readily accepted by farmers, even after a long period of time and some innovations are not at all accepted by the farmers. According to Rogers (1971), the farmers based on their innovativeness can be classified as 1) Innovators (Venturesome). 2) Early adopters (Respectable). 3) Early majority (Deliberate). 4) Late majority (Skeptical). 5) Laggards (Traditional). All members of a social system do not adopt an innovation at the same time. Rather, they adopt in an ordered time sequence, and they can be categorized as early adopters or late adopters depending on when they first use a new idea. It is highly useful for extension workers in a technology transfer programme to identify individuals who are likely to adopt innovations early and those who are likely to lag behind

Last chance to join Pirche's mission to revolutionize organ transplants  🔬 PIRCHE’s groundbreaking crowdfunding campaign on Invesdor DACH is closing soon—𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟰𝘁𝗵 is your last chance to get involved! ⏳ 💔 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? 50% of transplanted organs fail within 5–10 years, putting countless patients at risk. But Pirche is changing that reality. Their 𝗔𝗜-𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 matches donors and recipients with mind-blowing precision—in just three seconds! ⚡ 🔍 This innovation allows transplant specialists to predict the course of an organ transplant 𝘂𝗽 𝘁𝗼 𝟮𝟬 𝘆𝗲𝗮𝗿𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲, ensuring the best possible matches and transforming patient outcomes. Better-matched organs mean shorter waiting lists and a new lease on life for countless patients. 🌱 Pirche’s mission doesn’t end with kidneys—they’re expanding this life-saving technology to other organs. And 𝘁𝗵𝗲𝘆 𝗻𝗲𝗲𝗱 𝘆𝗼𝘂𝗿 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 to make it happen 🙌 💡 𝗝𝗼𝗶𝗻 𝗵𝘂𝗻𝗱𝗿𝗲𝗱𝘀 𝗼𝗳 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 who have already taken the leap to support Pirche’s vision. Become a co-owner in this health tech revolution and make a 𝗿𝗲𝗮𝗹 𝗶𝗺𝗽𝗮𝗰𝘁. 👉 Visit the campaign page via the link in the comments. 🚀 𝗗𝗼𝗻’𝘁 𝗺𝗶𝘀𝘀 𝗼𝘂𝘁! The campaign ends on 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟰𝘁𝗵—your chance to be part of something truly transformative. #crowdfunding #healthtech #organtransplant #pirche #invesdor #lastchance #medicalinnovation

#fundingalert 💼Company: Metyos 💰Funding: €2.3 Million ⚡Round: Pre-Seed 👥Investors: Kima Ventures, ADVANS Lab, and Bpifrance Large Venture Metyos is a medtech startup, founded by CEO Alexandre Boulanger and CTO Olga Chashchina,that’s on a mission to transform the lives of the 800 million+ chronic kidney disease (CKD) patients worldwide with its biowearable sensor and disease management platform. Metyos was founded to improve the lives, outcomes and costs associated with managing CKD – a disease that affects 10% of the population and is the third fastest-growing cause of death worldwide. Alexandre Boulanger Olga Chashchina Paul-Henri Fréret Rémi Rousseau Read more - https://lnkd.in/g7TXmSdt To share your startup story write us on - contact@startuprise.co.uk #metyos #medtech #worldwide #disease #biowearable #funding #startupnews #fundingnews #news

🧬 In this week's Austin Bio + Health Roundup, we're spotlighting the ecosystem coming together, more funding, strategic partnerships, and well deserved recognitions. 🧬 🏙️ Community This past week, I attended the 2nd Annual Life Science & Healthcare Innovation Summit, a remarkable gathering that brought together leaders from Austin and across the nation. With Jim Breyer and Jay Hartzell spearheading, the summit asked a pivotal question: How can we elevate the Austin Bio Health ecosystem to the next level? It was probably the best event I've ever attended in terms of the caliber of speakers, the depth of topics covered, and the distinguished attendees present. I could literally feel the flywheel turning! 💰 Funding BrainCheck has raised $15 million to fuel the expansion and adoption of its next-generation digital cognitive assessment and care planning platform. It's also testament to Austin funding Austin as the round was led by local firms Next Coast Ventures and S3 Ventures. Congratulations to Kim Rodriguez and the team! Check out my short interview below with Kim on what the round means what's next. Tiny Health, aiming to revolutionize baby gut health with microbiome tests, raised a $9M Series A. The local ecosystem continues to catalyze each other as Next Coast Ventures participated in the round. Keep up the momentum Cheryl Sew Hoy! The Dell Medical School has received a generous $5 million gift for establishing a rare disease center, underscoring the community's commitment to addressing challenging health conditions. 🤝 M&A and Partnerships Wheel expanded their Integrated Virtual Care Ecosystem with new companies Mark Cuban Cost Plus Drug Company, PBC, Talkspace, Health Gorilla, Candid Health, and HealthDyne. Form Bio is partnering with Ginkgo Bioworks, Inc. to develop industry-leading solutions new AAV gene therapy design and development. 🏆 Recognition The Helper Bees, Colossal Biosciences, and Diligent Robotics have all been named in Forbes' "Best Startup Employers," reflecting their impressive growth, reputation, and employee satisfaction. MatchDay Health has been spotlighted as a Top 100 company to watch by the FounderBeta Community. Kudos to Rami Wehbi, DO for this achievement! This week underscores the dynamic progress and collaborative spirit fueling our sector's growth. What's Next? #AustinNext #LifeSciences #Healthcare #Biotechnology